Predictors associated with sickle cell nephropathy: a systematic review
AUTOR(ES)
Maurício, Lauana; Ribeiro, Sara; Santos, Luciana; Miranda, Denismar Borges de
FONTE
Rev. Assoc. Med. Bras.
DATA DE PUBLICAÇÃO
2021-02
RESUMO
SUMMARY INTRODUCTION: Sickle cell anemia affects more than 30 million people worldwide. Chronic kidney disease develops in 40% of individuals. The death rate of patients with sickle nephropathy is still high, with little known predictors related to its development. To answer the question “What predictors are associated with the onset of chronic kidney disease in patients with sickle cell anemia?”, this article seeks to contribute to a better understanding of sickle nephropathy, making possible a new look at the sickle cell anemia and its kidney complications. METHODS: A systematic review was developed, using the PRISMA recommendation, for cohort studies on predictors related to the outcome of sickle nephropathy in patients with sickle cell anemia. RESULTS: Initially 321 studies were identified in Pubmed, of which six were selected to compose this systematic review. Lower hemoglobin levels, increased ages and albuminuria were the most pointed predictors associated with chronic kidney disease. CONCLUSION: The main predictors associated with the development of chronic kidney disease in individuals with sickle cell anemia were lower hemoglobin levels, increased ages, and albuminuria. New studies evaluating predictors for the development of chronic kidney disease in sickle cell anemia are needed to better understand its installation and prevent its progression.
Documentos Relacionados
- Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review
- Association Between Lipid Profile and Clinical Manifestations in Sickle Cell Anemia: A Systematic Review
- Predictors of excess birth weight in Brazil: a systematic review
- Cyclosporin treatment of IgA nephropathy: a short term controlled trial.
- Bradycardia associated with antithymocyte globulin treatment of a pediatric patient with sickle cell disease: a case report and literature review